Brian Sun
Consigliere Generale presso TURG POIN
Profilo
Brian Sun is currently the Senior Vice President & General Counsel at Turning Point Therapeutics, Inc. Prior to this, he worked as the Secretary, Senior VP & General Counsel at Sorrento Therapeutics, Inc. He holds a graduate degree from The Johns Hopkins University, an undergraduate degree from the University of California, Berkeley, and a graduate degree from the University of San Diego.
Posizioni attive di Brian Sun
| Società | Posizione | Inizio |
|---|---|---|
| TURG POIN | Consigliere Generale | 11/04/2022 |
Precedenti posizioni note di Brian Sun
| Società | Posizione | Fine |
|---|---|---|
| SORRENTO THERAPEUTICS, INC. | Consigliere Generale | - |
Formazione di Brian Sun
| University of San Diego | Graduate Degree |
| The Johns Hopkins University | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Brian Sun
